Publications by authors named "Laurence Duplomb"

42Publications

Neutralization of HSF1 in cells from PIK3CA-related overgrowth spectrum patients blocks abnormal proliferation.

Biochem Biophys Res Commun 2020 Sep 30;530(3):520-526. Epub 2020 Jun 30.

INSERM, LNC UMR1231 Team HSP-pathies, University of Burgundy and Franche-Comté, F-21000, Dijon, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2020.04.146DOI Listing
September 2020

Excess of de novo variants in genes involved in chromatin remodelling in patients with marfanoid habitus and intellectual disability.

J Med Genet 2020 Jul 10;57(7):466-474. Epub 2020 Apr 10.

INSERM, U1231, Génétique des Anomalies du Développement, Université de Bourgogne Franche-Comté, UMR Lipides, Nutrition, Dijon, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jmedgenet-2019-106425DOI Listing
July 2020

Vps13b is required for acrosome biogenesis through functions in Golgi dynamic and membrane trafficking.

Cell Mol Life Sci 2020 Feb 19;77(3):511-529. Epub 2019 Jun 19.

Inserm, UMR1231, Equipe GAD, Bâtiment B3, Université de Bourgogne Franche Comté, 15 boulevard du Maréchal de Lattre de Tassigny, 21000, Dijon Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00018-019-03192-4DOI Listing
February 2020

Extracellular HSP110 skews macrophage polarization in colorectal cancer.

Oncoimmunology 2016 Jul 22;5(7):e1170264. Epub 2016 Apr 22.

INSERM, LNC UMR866, Equipe Labellisée par la Ligue Nationale Contre le Cancer and Laboratoire d'Excellence LipSTIC, Dijon, France; Univ. Bourgogne Franche-Comté, LNC UMR866, Dijon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2016.1170264DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006898PMC
July 2016

Insulin response dysregulation explains abnormal fat storage and increased risk of diabetes mellitus type 2 in Cohen Syndrome.

Hum Mol Genet 2015 Dec 10;24(23):6603-13. Epub 2015 Sep 10.

Génétique des Anomalies du Développement GAD EA4271, Univeristé de Bourgogne Franche-Comté, F-21000 Dijon, France, FHU TRANSLAD, Département de Génétique, Hôpital d'enfants, CHU Dijon, F-21000 Dijon, France,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/ddv366DOI Listing
December 2015

Autosomal-recessive SASH1 variants associated with a new genodermatosis with pigmentation defects, palmoplantar keratoderma and skin carcinoma.

Eur J Hum Genet 2015 Jul 15;23(7):957-62. Epub 2014 Oct 15.

1] Equipe d'Accueil 4271, Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France [2] Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'Interrégion Est, Centre Hospitalier Universitaire Dijon, Dijon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ejhg.2014.213DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4463501PMC
July 2015

Delineation of the 3p14.1p13 microdeletion associated with syndromic distal limb contractures.

Am J Med Genet A 2014 Dec 24;164A(12):3027-34. Epub 2014 Sep 24.

Fédération Hospitalo-Universitaire TRANSLAD et Centre de Génétique et Centre de Référence «Anomalies du Développement et Syndromes Malformatifs» du Grand Est, Hôpital d'Enfants, CHU Dijon, Dijon, France; Université de Bourgogne, Dijon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajmg.a.36751DOI Listing
December 2014

Osteoprotegerin: multiple partners for multiple functions.

Cytokine Growth Factor Rev 2013 Oct 1;24(5):401-9. Epub 2013 Jul 1.

INSERM, UMR957, Nantes F-44035, France; Université de Nantes, Nantes atlantique universités, Laboratoire de Physiopathologie de la Résorption Osseuse et Thérapie des Tumeurs Osseuses Primitives, Nantes F-44035, France; CHU, Hôtel Dieu, Nantes, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cytogfr.2013.06.001DOI Listing
October 2013

Factor VIII-von Willebrand factor complex inhibits osteoclastogenesis and controls cell survival.

J Biol Chem 2009 Nov 16;284(46):31704-13. Epub 2009 Sep 16.

INSERM U957, Université de Nantes, Nantes Atlantique Universités, Laboratoire de Physiopathologie de la Résorption Osseuse et Thérapie des Tumeurs Osseuses Primitives, Nantes F-44035, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M109.030312DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797241PMC
November 2009

The dual role of IL-6-type cytokines on bone remodeling and bone tumors.

Cytokine Growth Factor Rev 2009 Feb 26;20(1):19-28. Epub 2008 Nov 26.

INSERM, ERI, Laboratoire de Physiopathologie de la Résorption Osseuse et Thérapie des Tumeurs Osseuses Primitives, Nantes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cytogfr.2008.11.004DOI Listing
February 2009

Interleukin-6 inhibits receptor activator of nuclear factor kappaB ligand-induced osteoclastogenesis by diverting cells into the macrophage lineage: key role of Serine727 phosphorylation of signal transducer and activator of transcription 3.

Endocrinology 2008 Jul 10;149(7):3688-97. Epub 2008 Apr 10.

EA3822-INSERM 7, ERI 7, and Laboratoire de Physiopathologie de la Résorption Osseuse et Thérapie des Tumeurs Osseuses Primitives, Université de Nantes, 1 rue Gaston Veil, Nantes Cedex 1, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/en.2007-1719DOI Listing
July 2008

Proteoglycans: key partners in bone cell biology.

Bioessays 2007 Aug;29(8):758-71

EA3822-INSERM ERI7, Physiopathologie de la Résorption Osseuse et Thérapie des Tumeurs Osseuses Primitives, Faculté de Médecine, 1 rue Gaston Veil, 44035 Nantes cedex 1, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/bies.20612DOI Listing
August 2007

Differentiation of osteoblasts from mouse embryonic stem cells without generation of embryoid body.

In Vitro Cell Dev Biol Anim 2007 Jan;43(1):21-4

INSERM, ERI 7, Nantes, 44035, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11626-006-9010-4DOI Listing
January 2007

Concise review: embryonic stem cells: a new tool to study osteoblast and osteoclast differentiation.

Stem Cells 2007 Mar 9;25(3):544-52. Epub 2006 Nov 9.

INSERM, ERI 7 Laboratoire de Physiopathologie de la Résorption Osseuse et Thérapie des Tumeurs Osseuses Primitives, EA3822, 1 rue Gaston Veil, 44035 Nantes Cedex 1.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/stemcells.2006-0395DOI Listing
March 2007

Independence of hyperleptinemia-induced fat disappearance from thyroid hormone.

Biochem Biophys Res Commun 2004 Oct;323(1):49-51

Gifford Laboratories, Department of Internal Medicine, Center for Diabetes Research, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2004.08.057DOI Listing
October 2004

Hyperleptinemia prevents lipotoxic cardiomyopathy in acyl CoA synthase transgenic mice.

Proc Natl Acad Sci U S A 2004 Sep 3;101(37):13624-9. Epub 2004 Sep 3.

Gifford Laboratories, Touchstone Center for Diabetes Research, University of Texas Southwestern Medical Center, Dallas, TX 75390-8854, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0405499101DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC518804PMC
September 2004

Demonstration of reverse fatty acid transport from rat cardiomyocytes.

J Lipid Res 2004 Nov 1;45(11):1992-9. Epub 2004 Sep 1.

Gifford Laboratories, Touchstone Center for Diabetes Research, Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1194/jlr.M400237-JLR200DOI Listing
November 2004

Hepatic insig-1 or -2 overexpression reduces lipogenesis in obese Zucker diabetic fatty rats and in fasted/refed normal rats.

Proc Natl Acad Sci U S A 2004 May 19;101(18):7106-11. Epub 2004 Apr 19.

Gifford Laboratories, Touchstone Center for Diabetes Research, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390-8854, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0401715101DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC406473PMC
May 2004

Increased expression and activity of 11beta-HSD-1 in diabetic islets and prevention with troglitazone.

Biochem Biophys Res Commun 2004 Jan;313(3):594-9

Gifford Laboratories, Center for Diabetes Research, Department of Internal Medicine, University of Texas Southwestern Medical center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2003.11.160DOI Listing
January 2004

Soluble mannose 6-phosphate/insulin-like growth factor II (IGF-II) receptor inhibits interleukin-6-type cytokine-dependent proliferation by neutralization of IGF-II.

Endocrinology 2003 Dec 28;144(12):5381-9. Epub 2003 Aug 28.

Group of Recherche Cytokines/Récepteurs/Transduction, Institut National de la Santé et de la Recherche Médicale, Unité 463, Nantes Cedex 01, France.

View Article

Download full-text PDF

Source
https://academic.oup.com/endo/article-lookup/doi/10.1210/en.
Publisher Site
http://dx.doi.org/10.1210/en.2003-0607DOI Listing
December 2003

FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins.

Oncogene 2002 Sep;21(41):6264-77

Department of Molecular and Cellular Biology, Roswell Park Cancer Institute, Buffalo, New York, NY 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1205777DOI Listing
September 2002